International Clinical Trial: A Two-center, Randomized, Double-blind, Placebo-controlled Study of Intravenous Plasma-purified Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125664) titled 'A Two-center, Randomized, Double-blind, Placebo-controlled Study of Intravenous Plasma-purified Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)' on Aug. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Condition: Acute Exacerbation Chronic Obstructive Pulmonary Disease

Intervention: Biological: alpha1-proteinase inhibitor, produced from the plasma of human donors (Prolastin 1000 mg, pow...